Related Experiment Video

Updated: Jul 5, 2026

Detection of Rare Mutations in CtDNA Using Next Generation Sequencing
11:11

Detection of Rare Mutations in CtDNA Using Next Generation Sequencing

Published on: August 24, 2017

Direct resequencing of the complete ERBB2 coding sequence reveals an absence of activating mutations in ERBB2

Christina I Zito1, David Riches, Julia Kolmakova

  • 1Department of Pathology, Yale University School of Medicine, New Haven, CT 06520, USA. christina.zito@yale.edu

Genes, Chromosomes & Cancer
|April 18, 2008
PubMed

Insights

This study introduces a novel high-throughput sequencing method for analyzing gene amplifications, specifically focusing on ERBB2. The technology proved effective for high-resolution analysis of amplified genes, despite not finding activating mutations in the tested samples.

Area of Science:

  • Genomics
  • Cancer Biology
  • Molecular Diagnostics

Background:

  • Gene amplification is a common driver of cancer, with ERBB2 amplification being particularly significant in various human cancers.
  • Both gene amplification and mutations in ERBB2 can predict patient response to targeted therapies.
  • Analyzing high-copy number gene amplifications presents significant technical challenges due to amplicon size and gene density.

Purpose of the Study:

  • To develop and validate a high-throughput sequencing method for high-resolution analysis of gene amplifications.
  • To investigate the mutational status of ERBB2 in cancer cell lines and tumors with known ERBB2 amplification.

Main Methods:

  • Utilized emulsion-based resequencing to analyze individual DNA molecules in parallel.
  • Applied high-throughput sequencing to ERBB2 amplicons from five cell lines and two tumors.
  • Performed emulsion PCR (emPCR) and picotiter plate pyrosequencing on pooled amplicons.

Main Results:

  • Successfully obtained high-quality sequence data for all analyzed ERBB2 amplicons.
  • No activating mutations were identified within the amplified ERBB2 copies in the studied samples.
  • Demonstrated the feasibility and cost-effectiveness of the developed technology for analyzing amplified genes.

Conclusions:

  • Emulsion-based resequencing is a powerful and cost-effective tool for high-resolution analysis of gene amplifications.
  • While no activating mutations were found in this ERBB2-amplified cohort, the technology is applicable to broader genomic studies.
  • This method overcomes technical challenges in analyzing complex amplicon structures in cancer genomics.

More Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
RACE - Rapid Amplification of cDNA Ends02:35

RACE - Rapid Amplification of cDNA Ends

Rapid Amplification of cDNA Ends, or RACE, is one of the most effective methods to obtain a full-length cDNA from an mRNA sequence between a known internal region to the unknown sequence at the 5’ or 3’ end. The unknown region is cloned in the cDNA by a gene-specific primer that binds the known end, and a hybrid primer that attaches a predefined anchor sequence to the unknown end of the cDNA. The sequence in between is amplified by PCR with an anchor primer and a gene-specific primer.
Since the...